Roche Holding AG

Roche Holding AG is a Swiss multinational holding healthcare company headquartered in Basel, Switzerland, founded in 1896. It operates worldwide through two primary divisions: Pharmaceuticals and Diagnostics, focusing on developing and providing innovative medicines and diagnostic solutions. The Pharmaceuticals division targets major disease areas including oncology, where it leads globally in cancer treatments, as well as neurology, immunology, infectious diseases, ophthalmology, haemophilia, and diseases of the respiratory system and cardiovascular-metabolic conditions. Key subsidiaries like the fully owned Genentech and Chugai Pharmaceuticals bolster its biotechnology capabilities. The Diagnostics division produces equipment and reagents for research, professional diagnostics, diabetes care, molecular diagnostics, and tissue diagnostics, serving physicians, hospitals, clinics, and consumers. Roche Holding AG integrates pharma and diagnostics to enhance health outcomes, offering products that support early disease detection, personalized treatments, and global access programs for diagnostics in areas like hepatitis, TB, HPV, and COVID-19. Its portfolio emphasizes transformative solutions across non-communicable and infectious diseases, playing a pivotal role in advancing healthcare worldwide.